NEW YORK (GenomeWeb News) – Orchid Cellmark today reported that its fourth-quarter and fiscal 2008 revenues declined due to lower UK revenues and a decline in revenues from forensic casework and its CODIS business.

Orchid brought in total revenues of $13 million for the three-month period ended Dec. 31, a drop of 13 percent from revenues of $15 million for the fourth quarter of 2007.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.